Applera and Bio-Rad Enter Settlement Discussions over Patent Infringement Lawsuit
Applera Corporation and Bio-Rad Laboratories announced both parties are conducting settlement discussions concerning the patent infringement lawsuit brought by Applera and Roche Molecular Systems (Roche) against MJ Research in the U.S. District Court for the District of Connecticut. The goal of these discussions is a resolution of all outstanding disputes in the U.S. between the two companies.
Applera Corporation and Roche Molecular Systems originally filed this patent infringement lawsuit in June 1998 against MJ Research relating to certain PCR patents owned by Applera and Roche, and a jury decided in favor of Applera and Roche in 2004. The Court also issued a permanent injunction in September 2005 prohibiting Bio-Rad, as the successor of MJ Research, from manufacturing, selling or servicing infringing thermal cycler products in the U.S. Various post-trial motions remain pending in the case.
No further details of the discussions have yet been made public.
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Crucell Announces Positive Results of Phase II Rabies Monoclonal Antibody Combination Clinical Study in Philippines
Basilea's antifungal isavuconazole passed phase III clinical trial futility analysis

Degrading modified proteins could treat Alzheimer’s, other ‘undruggable’ diseases - New technique specifically targets and breaks apart certain proteins — rather than just interfering with them
Evonik invests in the feed amino acid L-lysine in Brazil and Russia - Investments of approx. €350 million
Rockeby European patent granted for CanDia5

SUANFARMA announces a collaboration with Reyoung Pharmaceutical - The main objective of the collaboration is to introduce generic pharmaceutical ingredients to the market for the treatment of infectious diseases
Bayer: YAZ approved in Japan for the treatment of dysmenorrhea

Nanoparticles used to transport anti-cancer agent to cells
